Sign In
Buy TMCI
$4.31
-0.0700 (-1.60%)
At Close: Jul 31, 2026
CEOs and Other Insiders Are Buying Shares of These 7 Stocks
09:45am, Sunday, 19'th May 2024
With the earnings-reporting season winding down, the windows for making insider purchases are opening up.
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
05:11pm, Friday, 17'th May 2024
NEW YORK--(BUSINESS WIRE)-- #Investigation--The law firm of Kirby McInerney LLP is investigating potential claims against Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMC
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
06:34pm, Thursday, 16'th May 2024
NEW YORK , May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). Such investors are ad
Treace Medical Concepts Inc (TMCI) Q1 2024 Earnings Call Transcript
11:05am, Saturday, 11'th May 2024
Treace Medical Concepts Inc (NASDAQ:TMCI ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Julie Dewey - Chief Communications & Investor Relations Officer John Treace - Fo
Why Is Treace Medical Concepts (TMCI) Stock Down 59% Today?
08:34am, Wednesday, 08'th May 2024
Treace Medical Concepts (NASDAQ: TMCI ) stock is falling hard on Wednesday following the release of the medical technology company's Q1 2024 earnings report. The problem comes from the company's guid
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates
06:31pm, Tuesday, 07'th May 2024
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.30 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.23 per share a year ago.
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
07:00am, Wednesday, 24'th Apr 2024
Partnership to help pickleball players of all levels with bunions and related midfoot deformities to “get back on their feet” and out on the court Partnership to help pickleball players of all lev
Treace to Present at Bank of America Health Care Conference
07:00am, Wednesday, 17'th Apr 2024
PONTE VEDRA, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
Treace Announces First Annual National Bunion Day
07:00am, Tuesday, 16'th Apr 2024
Focus on Foot Health Issue Affecting Millions of People Includes Outreach and Education Efforts to Build Awareness, Reduce Stigma and Correct Misconceptions About This Common Bone Deformity Focus on F
7 Stable Stocks for 50% Returns by Early 2025
09:45am, Monday, 15'th Apr 2024
Investors who seek 50% returns in less than 12 months generally will have many choices within stable stocks. The general maxim regarding risk and return applies here: Risky, unstable stocks tend to of
Treace to Report First Quarter 2024 Financial Results
07:00am, Tuesday, 09'th Apr 2024
Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
07:00am, Monday, 25'th Mar 2024
Treace Further Expands Focus on Bunion Deformity Education by Sponsoring First-Ever National Bunion Day in the U.S. on April 16, 2024
Treace Medical Concepts Inc (TMCI) Q4 2023 Earnings Call Transcript
09:14pm, Wednesday, 28'th Feb 2024
Treace Medical Concepts Inc (TMCI) Q4 2023 Earnings Call Transcript
Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates
07:36pm, Tuesday, 27'th Feb 2024
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.08 per share a year ago.
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
04:05pm, Tuesday, 27'th Feb 2024
PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
